| Muscular Dystrophy |
1 |
1 |
| Steroids |
0 |
0.74 |
| Fractures |
0 |
0.44 |
| Patient Safety |
0 |
0.38 |
| Lipids Management |
0 |
0.35 |
| Corticosteroids |
0 |
0.33 |
| Dystrophinopathies |
0 |
0.33 |
| Child |
0 |
0.25 |
| Spinal Fractures and Dislocations |
0 |
0.18 |
| Adverse Effects |
0 |
0.16 |
| Board Certification |
0 |
0.16 |
| Hospital |
0 |
0.16 |
| Biologic Therapy |
0 |
0.13 |
| Cataract |
0 |
0.13 |
| Medical Life |
0 |
0.13 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.13 |
| Skin Cancer |
0 |
0.13 |
| Weight Management |
0 |
0.13 |
| Fellowship |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.08 |
| Heart |
0 |
0.08 |
| Histone Deacetylase Inhibitor |
0 |
0.08 |
| Jobs |
0 |
0.08 |
| Missouri |
0 |
0.08 |
| Ohio |
0 |
0.08 |
| Platelet Count |
0 |
0.08 |
| Pollex |
0 |
0.08 |
| Targeted Cancer Therapy |
0 |
0.08 |
| Triglycerides |
0 |
0.08 |
| Vertebral Fracture |
0 |
0.08 |
| Washington |
0 |
0.08 |
| Weight Gain |
0 |
0.08 |